PHARMACOKINETICS AND METABOLISM OF C-14 ISEPAMICIN IN HUMANS FOLLOWING INTRAVENOUS ADMINISTRATION

被引:7
作者
LIN, C [1 ]
KORDUBA, C [1 ]
AFFRIME, M [1 ]
RADWANSKI, E [1 ]
NOMEIR, A [1 ]
BATRA, V [1 ]
CUTLER, D [1 ]
CAYEN, MN [1 ]
机构
[1] SCHERING PLOUGH CORP,RES INST,DEPT CLIN PHARMACOL,KENILWORTH,NJ 07033
关键词
D O I
10.1128/AAC.39.10.2201
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Twelve healthy adult male volunteers received Ig (base equivalent) of C-14-isepamicin (131 mu Ci) as an intravenous bolus over 5 min. The areas under the plasma concentration-time curves at infinity for isepamicin (196 mu g . h/ml) and total radioactivity (164 mu g . h/ml) were similar, indicating no biotransformation of isepamicin. The disappearance of isepamicin from plasma followed a triexponential decline, with half-lives of 0.17, 2.12, and 34 h for the alpha, beta, and gamma phases, respectively. However, the contribution of the gamma phase to the total area under the concentration-time curve was only 2.6%. There were no detectable metabolites in plasma and urine, confirming that isepamicin was not biotransformed. The cumulative levels of isepamicin and total radioactivity excretion in urine from 0 to 120 h were 97.3 and 92.1% of the dose, respectively, indicating that the drug was excreted mainly as unchanged isepamicin in urine.
引用
收藏
页码:2201 / 2203
页数:3
相关论文
共 25 条
[1]  
AONUMA S, 1985, CHEMOTHERAPY-TOKYO, V33, P149
[2]   NETILMICIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE [J].
CAMPOLIRICHARDS, DM ;
CHAPLIN, S ;
SAYCE, RH ;
GOA, KL .
DRUGS, 1989, 38 (05) :703-756
[3]   COMPARISON OF NETILMICIN AND GENTAMICIN PHARMACOKINETICS IN HUMANS [J].
CHUNG, M ;
COSTELLO, R ;
SYMCHOWICZ, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (02) :184-187
[4]   PHARMACOKINETIC STUDY OF SISOMICIN IN HUMANS [J].
CHUNG, M ;
SCHROGIE, JJ ;
SYMCHOWICZ, S .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (05) :535-551
[5]  
GLUPCZYNSKI Y, 1988, 28TH INT C ANT AG CH, P376
[6]  
GOMEZLUS ML, 1988, 28TH INT C ANT AG CH, P376
[7]  
HARE RS, 1980, CURR CHEMOTHER INFEC, V1, P403
[8]  
HARE RS, 1988, 28TH INT C ANT AG CH
[9]   PHARMACOKINETICS OF NETILMICIN IN PRESENCE OF NORMAL OR IMPAIRED RENAL-FUNCTION [J].
HUMBERT, G ;
LEROY, A ;
FILLASTRE, JP ;
OKSENHENDLER, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 14 (01) :40-44
[10]  
IKEDA DP, 1982, 22ND INT C ANT AG CH, P130